11 | $PBM Lod1.69 RL.75 + LL.51 off | znewcar1 | 03/11/2024 12:47:58 PM |
10 | PBM 3.81 Pacific Booker Minerals Inc $PBM stock | clayton | 12/11/2014 12:44:27 PM |
9 | PBM Stock is number 28 for the largest percentage | danrocks | 12/11/2014 10:42:17 AM |
8 | PBM Stock year to date has changed -43.62% | Jake13 | 12/10/2014 5:31:10 AM |
7 | PBM 3.71 Pacific Booker Minerals Inc Stock Charts | chartguy89 | 12/10/2014 5:05:52 AM |
6 | PBM Year to date has changed -44.68% percent. | Jake13 | 11/21/2014 4:21:18 AM |
5 | PBM 3.64 Pacific Booker Minerals Inc Stock Charts | chartguy89 | 11/21/2014 3:57:38 AM |
4 | PBM Year to date has changed -43.01% percent. | Jake13 | 11/15/2014 4:36:33 AM |
3 | PBM 3.75 Pacific Booker Minerals Inc Stock Charts | chartguy89 | 11/15/2014 4:06:08 AM |
2 | PBM 3.67 Pacific Booker Minerals Inc Stock Charts | chartguy89 | 11/11/2014 8:47:03 AM |
1 | PBM Year to date has changed -44.22% percent. | Jake13 | 11/11/2014 7:44:24 AM |
Recent Articles
- Revolution Medicines Unveils Promising Data on Zoldonrasib
- Bishop T.D. Jakes Transfers Leadership to Touré and Sarah Roberts
- SpringWorks Therapeutics Insights on Nirogacestat Outlook and Growth
- Memorable Grand Opening Weekend at The Tryst Puerto Vallarta
- TCL Electronics Sees Remarkable Growth in Global TV Shipments
- Transforming the Auto Industry: AutoShop and Rilla's Partnership
- Appotronics Unveils Innovative Vehicle Projection Technology
- Hikvision's 2024 Financial Success and Future Innovations
- AppLovin Investors Urged to Join Class Action Lawsuit Today
- Hikvision's 2024 ESG Report Paves the Path for Sustainability
- Updates for Ultra Clean Investors on Class Action Details
- Important Update for Ready Capital Investors About Legal Action
- Discovering Relmada's Innovative Bladder Cancer Treatment Approach
- Investor Insights on NET Power's Class Action Lawsuit Dynamics
- Exciting Details About the Upcoming Zeigler Kalamazoo Marathon
- Investors Alert: e.l.f. Beauty Class Action Lawsuit Announced
- Understanding the Importance of Class Actions for Geron Investors
- Exciting Innovations Unveiled at Upcoming Hong Kong Shows
- Understanding the Skyworks Class Action and Your Rights
- Understanding the Class Action Lawsuit Against Fluence Energy
- Investigation into Open Lending Holdings for Investor Losses
- Investor Alert: Take Action on The Bancorp Class Action Today!
- Zynex Investors Urged to Join Class Action Before Deadline
- Investors Urged to Act in Rocket Lab Class Action Case
- Understanding Class Action Insights for TFI International Investors
- Innovative Publications by Dr. Tamara Moodie Transform Autism Awareness
- Empowering Women in Motorsports: Rally Jameel Champions
- Revolutionizing Environmental Safety with Raytron's Technologies
- Innovative Bathroom Solutions Shine at Major International Fair
- Raytron Innovations in Thermal Imaging for Climate Protection
- Innovative Bathroom Solutions Highlighted at Global Trade Fair
- iMENA Holding Transforms into a Digital Market Leader
- CoinEx Celebrates Major Recognition for Crypto Trading App
- ChangAn's Ambitious Plans for Global Growth by 2030
- Exploring Innovation at the Canton Fair with Jason
- ChangAn's Ambitious 2030 Vision and Global Expansion Plans
- Yutong Bus Revolutionizes Vehicle Service with EnRoute+ Launch
- LONGi's Jiaxing Factory Shines as a Model for Zero-Carbon Innovation
- Bestzyme's Mellia™ Brazzein Gains FDA Approval for Healthier Choices
- Yiwu's Resilient Businesses Thrive Amid Tariff Challenges
- Yutong Bus Introduces Innovative EnRoute+ Service Framework
- Abbott's Volt PFA System: Key Insights on Long-Term Outcomes
- Abbott's Volt PFA System Shows Promising Long-Term Benefits
- Innovative Atrial Fibrillation Solutions by Medtronic
- XploraDEX $XPL Presale Climaxes in Excitement and Urgency
- Legendary Builder Akira Nakai Showcases Talent at Auto Show
- CG Oncology's Cretostimogene Shows Promising Durability in Trials
- Exploring IO Biotech's Impact on Cancer Vaccine Innovation
- Top Muscle Gain Pre-Workouts: Choose the Best for Gains
- Medtronic’s Hugo™ RAS System Achieves Key Clinical Trial Milestone